These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23661628)

  • 1. Metabolic regulation of osteoclast differentiation and function.
    Indo Y; Takeshita S; Ishii KA; Hoshii T; Aburatani H; Hirao A; Ikeda K
    J Bone Miner Res; 2013 Nov; 28(11):2392-9. PubMed ID: 23661628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice.
    Zhao X; Petrashen AP; Sanders JA; Peterson AL; Sedivy JM
    Aging Cell; 2019 Jun; 18(3):e12947. PubMed ID: 30909319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between
    Tsumura H; Shindo M; Ito M; Igarashi A; Takeda K; Matsumoto K; Ohkura T; Miyado K; Sugiyama F; Umezawa A; Ito Y
    Comp Med; 2021 Aug; 71(4):285-294. PubMed ID: 34301346
    [No Abstract]   [Full Text] [Related]  

  • 6. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminolysis provides nucleotides and amino acids to regulate osteoclast differentiation in mice.
    Hu G; Yu Y; Ren Y; Tower RJ; Zhang GF; Karner CM
    EMBO Rep; 2024 Oct; 25(10):4515-4541. PubMed ID: 39271775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation.
    Li B; Lee WC; Song C; Ye L; Abel ED; Long F
    FASEB J; 2020 Aug; 34(8):11058-11067. PubMed ID: 32627870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.
    Ahn H; Lee K; Kim JM; Kwon SH; Lee SH; Lee SY; Jeong D
    PLoS One; 2016; 11(4):e0153886. PubMed ID: 27077737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.
    Cai ZY; Yang B; Shi YX; Zhang WL; Liu F; Zhao W; Yang MW
    Biochem Biophys Res Commun; 2018 Sep; 503(2):428-435. PubMed ID: 29649480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL).
    Ang ES; Zhang P; Steer JH; Tan JW; Yip K; Zheng MH; Joyce DA; Xu J
    J Cell Physiol; 2007 Sep; 212(3):787-95. PubMed ID: 17477372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade.
    Choudhury M; Schaefbauer KJ; Kottom TJ; Yi ES; Tschumperlin DJ; Limper AH
    Am J Respir Cell Mol Biol; 2023 Oct; 69(4):441-455. PubMed ID: 37459644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
    Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
    Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
    Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-myc is required for osteoclast differentiation.
    Battaglino R; Kim D; Fu J; Vaage B; Fu XY; Stashenko P
    J Bone Miner Res; 2002 May; 17(5):763-73. PubMed ID: 12009006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription.
    Zhang W; Xu Y; Xu Q; Shi H; Shi J; Hou Y
    Carcinogenesis; 2017 Jul; 38(7):748-755. PubMed ID: 28419191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural uranium impairs the differentiation and the resorbing function of osteoclasts.
    Gritsaenko T; Pierrefite-Carle V; Lorivel T; Breuil V; Carle GF; Santucci-Darmanin S
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):715-726. PubMed ID: 28089586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.
    Ng PY; Cheng TS; Zhao H; Ye S; Sm Ang E; Khor EC; Feng HT; Xu J; Zheng MH; Pavlos NJ
    J Bone Miner Res; 2013 Jan; 28(1):119-34. PubMed ID: 22887640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.